売上高・売上総利益率の推移
| 年度 |
売上高 |
売上総利益率 |
| 2024/12 |
2,808 |
72.4% |
| 2023/12 |
2,748 |
69.8% |
| 2022/12 |
2,566 |
71.0% |
| 2021/12 |
2,329 |
71.9% |
| 2020/12 |
1,726 |
73.1% |
| 2019/12 |
818 |
|
| 2018/12 |
604 |
|
| 2017/12 |
441 |
|
| 2016/12 |
365 |
|
| 2015/12 |
273 |
|
営業利益・営業利益率の推移
| 年度 |
営業利益 |
営業利益率 |
| 2024/12 |
380,208 |
13.5% |
| 2023/12 |
279,841 |
10.2% |
| 2022/12 |
-658,560 |
-25.7% |
| 2021/12 |
465,732 |
20.0% |
| 2020/12 |
424,009 |
24.6% |
| 2019/12 |
88,761 |
|
| 2018/12 |
74,786 |
|
| 2017/12 |
11,896 |
|
| 2016/12 |
17,577 |
|
| 2015/12 |
-1,884 |
|
|
(単位:百万ドル)
|
2015/12
|
2016/12
|
2017/12
|
2018/12
|
2019/12
|
2020/12
|
2021/12
|
2022/12
|
2023/12
|
2024/12
|
|
売上高
|
273
|
364
|
441
|
603
|
818
|
1,725
|
2,329
|
2,566
|
2,748
|
2,808
|
|
売上成長率(%)
|
-
|
|
|
|
|
110.9
|
35.0
|
10.2
|
7.1
|
2.2
|
|
売上原価
|
96
|
123
|
150
|
190
|
271
|
464
|
654
|
744
|
828
|
774
|
|
売上総利益
|
176
|
241
|
290
|
412
|
547
|
1,260
|
1,674
|
1,821
|
1,919
|
2,033
|
|
売上総利益率(%)
|
|
|
|
|
|
73.1
|
71.9
|
71.0
|
69.8
|
72.4
|
|
研究開発費
|
42
|
55
|
74
|
97
|
121
|
180
|
271
|
412
|
469
|
443
|
|
営業費用
|
178
|
224
|
278
|
338
|
458
|
836
|
1,208
|
2,480
|
1,639
|
1,653
|
|
営業利益
|
-2
|
17
|
11
|
74
|
88
|
424
|
465
|
-659
|
279
|
380
|
|
営業利益率 (%)
|
|
|
|
|
|
24.6
|
20.0
|
-25.7
|
10.2
|
13.5
|
|
経常(税引前)利益
|
-28
|
-3
|
32
|
55
|
80
|
365
|
471
|
-662
|
292
|
410
|
|
経常(税引前)利益率(%)
|
-10.2
|
-0.8
|
7.3
|
9.1
|
9.9
|
21.2
|
20.3
|
-25.8
|
10.7
|
14.6
|
|
法人税等合計
|
26
|
27
|
-50
|
-23
|
-16
|
16
|
-22
|
32
|
-15
|
107
|
|
実効税率(%)
|
|
|
|
|
|
4.5
|
-4.6
|
-4.9
|
-5.0
|
26.2
|
|
純利益
|
-55
|
-30
|
81
|
77
|
95
|
349
|
493
|
-695
|
307
|
303
|
|
純利益率(%)
|
|
|
|
|
|
20.2
|
21.2
|
-27.1
|
11.2
|
10.8
|
|
一株あたり利益
|
-
|
-
|
0.69
|
0.64
|
0.8
|
2.88
|
3.88
|
-5.48
|
2.51
|
2.64
|
|
希薄化後一株あたり利益
|
-
|
-
|
0.68
|
0.61
|
0.76
|
2.69
|
3.4
|
-5.48
|
2.24
|
2.35
|
|
EBITDA
|
|
|
|
|
|
482
|
539
|
-562
|
371
|
488
|
|
EBITDAマージン(%)
|
|
|
|
|
|
27.9
|
23.2
|
-21.9
|
13.5
|
17.4
|